Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 45, 2010 - Issue 4
Submit an article Journal homepage
103
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

Emmanouil SinakosCorrespondence[email protected]
,
Ioannis Dedes Interbalkan Medical Center, Thessaloniki, Greece
,
Lavrentis Papalavrentios
,
Antonios Drevelegas
&
Evangelos Akriviadis
Pages 511-512 | Received 27 Nov 2009, Accepted 14 Jan 2010, Published online: 29 Jan 2010

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Giuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, Chiara Genco, Tiziana Pressiani, Francesca Spada & Rodolfo Sacco. (2011) Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib. Expert Review of Anticancer Therapy 11:12, pages 1807-1816.
Read now

Articles from other publishers (3)

Joshua L. Weintraub & Riad Salem. (2013) Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science. Journal of Vascular and Interventional Radiology 24:8, pages 1123-1134.
Crossref
Jean-François Dufour, Hanno Hoppe, Markus H. Heim, Beat Helbling, Olivier Maurhofer, Zsolt Szucs-Farkas, Ralph Kickuth, Markus Borner, Daniel Candinas & Bettina Saar. (2010) Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study. The Oncologist 15:11, pages 1198-1204.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:11, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.